Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan
· Delayed Price · Currency is TWD 32.80
+0.25 (0.77%)
Jun 6, 2025, 1:35 PM CST
Taiyen Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 3,244 | 3,238 | 3,409 | 3,614 | 4,096 | 3,130 | Upgrade
|
| Revenue Growth (YoY) | -3.37% | -5.01% | -5.67% | -11.77% | 30.84% | 7.70% | Upgrade
|
| Cost of Revenue | 1,933 | 1,917 | 2,151 | 2,337 | 2,722 | 1,823 | Upgrade
|
| Gross Profit | 1,311 | 1,321 | 1,257 | 1,277 | 1,373 | 1,308 | Upgrade
|
| Selling, General & Admin | 845.61 | 835.39 | 801.98 | 770.92 | 786.46 | 770.29 | Upgrade
|
| Research & Development | 55.32 | 54.71 | 60.5 | 60.64 | 57.6 | 73.98 | Upgrade
|
| Operating Expenses | 953.18 | 974.38 | 936.04 | 831.56 | 844.06 | 844.27 | Upgrade
|
| Operating Income | 358.27 | 346.53 | 321.44 | 445.05 | 529.18 | 463.32 | Upgrade
|
| Interest Expense | -6.74 | -6.34 | -3.35 | -4.52 | -5.94 | -3.61 | Upgrade
|
| Interest & Investment Income | 37.35 | 37.93 | 35.93 | 17.88 | 10.66 | 15.19 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -0.55 | Upgrade
|
| Currency Exchange Gain (Loss) | 22.34 | 38.54 | -5.67 | 58.69 | -20.59 | -16.64 | Upgrade
|
| Other Non Operating Income (Expenses) | 14.8 | 11 | -21.26 | 20.65 | 1.93 | 4.92 | Upgrade
|
| EBT Excluding Unusual Items | 426.02 | 427.66 | 327.1 | 537.74 | 515.23 | 462.62 | Upgrade
|
| Gain (Loss) on Sale of Investments | 11.58 | 12.85 | 7.43 | -0.36 | -0.54 | 3.17 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.04 | -1.04 | -1.28 | -1.28 | -1.24 | -1.76 | Upgrade
|
| Other Unusual Items | -6.46 | -6.44 | -4.13 | -5.52 | -3.54 | - | Upgrade
|
| Pretax Income | 430.1 | 433.03 | 329.12 | 530.59 | 509.92 | 464.04 | Upgrade
|
| Income Tax Expense | 109.87 | 115.58 | 111.82 | 103.07 | 97.76 | 89.45 | Upgrade
|
| Earnings From Continuing Operations | 320.23 | 317.45 | 217.3 | 427.52 | 412.16 | 374.59 | Upgrade
|
| Minority Interest in Earnings | 44.18 | 54.07 | 83.09 | -0.81 | -18.94 | -9.5 | Upgrade
|
| Net Income | 364.42 | 371.52 | 300.39 | 426.7 | 393.23 | 365.09 | Upgrade
|
| Net Income to Common | 364.42 | 371.52 | 300.39 | 426.7 | 393.23 | 365.09 | Upgrade
|
| Net Income Growth | 22.85% | 23.68% | -29.60% | 8.51% | 7.71% | 5.67% | Upgrade
|
| Shares Outstanding (Basic) | 200 | 200 | 200 | 200 | 200 | 200 | Upgrade
|
| Shares Outstanding (Diluted) | 201 | 201 | 200 | 201 | 201 | 201 | Upgrade
|
| Shares Change (YoY) | 0.06% | 0.06% | -0.08% | 0.05% | - | 0.02% | Upgrade
|
| EPS (Basic) | 1.82 | 1.86 | 1.50 | 2.13 | 1.97 | 1.83 | Upgrade
|
| EPS (Diluted) | 1.82 | 1.85 | 1.50 | 2.13 | 1.96 | 1.82 | Upgrade
|
| EPS Growth | 22.98% | 23.33% | -29.58% | 8.67% | 7.69% | 5.81% | Upgrade
|
| Free Cash Flow | 244.28 | 352.51 | 112.89 | 334.58 | 211.29 | 74.59 | Upgrade
|
| Free Cash Flow Per Share | 1.22 | 1.76 | 0.56 | 1.67 | 1.05 | 0.37 | Upgrade
|
| Dividend Per Share | 1.300 | 1.300 | 1.200 | 1.500 | 1.500 | 1.350 | Upgrade
|
| Dividend Growth | 8.33% | 8.33% | -20.00% | - | 11.11% | -10.00% | Upgrade
|
| Gross Margin | 40.43% | 40.79% | 36.89% | 35.33% | 33.53% | 41.77% | Upgrade
|
| Operating Margin | 11.04% | 10.70% | 9.43% | 12.32% | 12.92% | 14.80% | Upgrade
|
| Profit Margin | 11.23% | 11.47% | 8.81% | 11.81% | 9.60% | 11.66% | Upgrade
|
| Free Cash Flow Margin | 7.53% | 10.89% | 3.31% | 9.26% | 5.16% | 2.38% | Upgrade
|
| EBITDA | 574.51 | 553.56 | 508.88 | 628.74 | 707.81 | 640.44 | Upgrade
|
| EBITDA Margin | 17.71% | 17.09% | 14.93% | 17.40% | 17.28% | 20.46% | Upgrade
|
| D&A For EBITDA | 216.24 | 207.03 | 187.44 | 183.69 | 178.64 | 177.12 | Upgrade
|
| EBIT | 358.27 | 346.53 | 321.44 | 445.05 | 529.18 | 463.32 | Upgrade
|
| EBIT Margin | 11.04% | 10.70% | 9.43% | 12.32% | 12.92% | 14.80% | Upgrade
|
| Effective Tax Rate | 25.55% | 26.69% | 33.98% | 19.43% | 19.17% | 19.28% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.